Stryker (SYK) Return on Capital Employed (2009 - 2026)
Stryker (SYK) reported Return on Capital Employed of 12.24% for Q1 2026, up 252.0% year-over-year from 3.48% in Q1 2025, and down 0.72% quarter-over-quarter from 12.33% in Q4 2025.
Stryker (SYK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Return on Capital Employed data on file, last reported at 12.24% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 12.24%, up 252.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 12.24% (up 252.0% YoY), and the FY2025 annual result was 13.0%, up 209.0% from the prior year.
- Return on Capital Employed fell to 12.24% in Q1 2026 per SYK's latest filing, from 12.33% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 13.02% in Q2 2024 and troughed at 8.24% in Q2 2022.
- A 5-year average of 10.69% and a median of 10.31% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed soared 309 bps in 2023, then slumped 372 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 9.43% in 2022, then jumped by 33 bps to 12.52% in 2023, then declined by 18 bps to 10.31% in 2024, then advanced by 20 bps to 12.33% in 2025, then declined by 1 bps to 12.24% in 2026.
- Business Quant data shows SYK's Return on Capital Employed at 12.24% in Q1 2026, 12.33% in Q4 2025, and 9.33% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.24% |
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | 9.30% |
| Mar 31, 2025 | 9.72% |
| Dec 31, 2024 | 10.31% |
| Sep 30, 2024 | 12.91% |
| Jun 30, 2024 | 13.02% |
| Mar 31, 2024 | 12.61% |
| Dec 31, 2023 | 12.52% |
| Sep 30, 2023 | 11.38% |
| Jun 30, 2023 | 10.88% |
| Mar 31, 2023 | 10.10% |
| Dec 31, 2022 | 9.43% |
| Sep 30, 2022 | 9.05% |
| Jun 30, 2022 | 8.24% |
| Mar 31, 2022 | 8.30% |
| Dec 31, 2021 | 8.66% |
| Sep 30, 2021 | 8.53% |
| Jun 30, 2021 | 9.54% |